Line 8: | Line 8: | ||
We relied heavily on three basic parts from the Registry (CMV,GAL4 and VP16), and so we changed several sites to optimize them. We designed a new composite part BBa_K2580666 to express GAL4-VP16, an potent transcriptional activator[1] , to drive other parts’ expression. | We relied heavily on three basic parts from the Registry (CMV,GAL4 and VP16), and so we changed several sites to optimize them. We designed a new composite part BBa_K2580666 to express GAL4-VP16, an potent transcriptional activator[1] , to drive other parts’ expression. | ||
</p> | </p> | ||
− | + | <br/><br/> | |
− | < | + | <h1>Reference</h1> |
− | <p> | + | <p></p> |
</div> | </div> | ||
Revision as of 22:47, 17 October 2018
Parts Overview
We relied heavily on three basic parts from the Registry (CMV,GAL4 and VP16), and so we changed several sites to optimize them. We designed a new composite part BBa_K2580666 to express GAL4-VP16, an potent transcriptional activator[1] , to drive other parts’ expression.